Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Triaryl-substituted Schiff bases are high-affinity subtype-selective ligands for the estrogen receptor.

Liao ZQ, Dong C, Carlson KE, Srinivasan S, Nwachukwu JC, Chesnut RW, Sharma A, Nettles KW, Katzenellenbogen JA, Zhou HB.

J Med Chem. 2014 Apr 24;57(8):3532-45. doi: 10.1021/jm500268j. Epub 2014 Apr 7.

2.

Recognition of variant HIV-1 epitopes from diverse viral subtypes by vaccine-induced CTL.

McKinney DM, Skvoretz R, Livingston BD, Wilson CC, Anders M, Chesnut RW, Sette A, Essex M, Novitsky V, Newman MJ.

J Immunol. 2004 Aug 1;173(3):1941-50.

3.

A decaepitope polypeptide primes for multiple CD8+ IFN-gamma and Th lymphocyte responses: evaluation of multiepitope polypeptides as a mode for vaccine delivery.

Alexander J, Oseroff C, Dahlberg C, Qin M, Ishioka G, Beebe M, Fikes J, Newman M, Chesnut RW, Morton PA, Fok K, Appella E, Sette A.

J Immunol. 2002 Jun 15;168(12):6189-98.

4.

T-lymphocyte epitope identification and their use in vaccine development for HIV-1.

Newman MJ, Livingston B, McKinney DM, Chesnut RW, Sette A.

Front Biosci. 2002 Jun 1;7:d1503-15. Review.

PMID:
12048179
5.

Molecular determinants of peptide binding to two common rhesus macaque major histocompatibility complex class II molecules.

Dzuris JL, Sidney J, Horton H, Correa R, Carter D, Chesnut RW, Watkins DI, Sette A.

J Virol. 2001 Nov;75(22):10958-68.

6.

Dendritic cells generated in vivo by a chimeric hematopoietic growth factor, progenipoietin-4, demonstrate potent immunological function.

Ishioka GY, Fikes J, Qin M, Gianfrani C, Chesnut RW, Kahn LE, Streeter PR, Woulfe SL, Sette A.

Vaccine. 2001 Jun 14;19(27):3710-9.

PMID:
11395205
7.

Overcoming T cell tolerance to the hepatitis B virus surface antigen in hepatitis B virus-transgenic mice.

Sette AD, Oseroff C, Sidney J, Alexander J, Chesnut RW, Kakimi K, Guidotti LG, Chisari FV.

J Immunol. 2001 Jan 15;166(2):1389-97.

8.

Human memory CTL response specific for influenza A virus is broad and multispecific.

Gianfrani C, Oseroff C, Sidney J, Chesnut RW, Sette A.

Hum Immunol. 2000 May;61(5):438-52.

PMID:
10773346
9.

Linear PADRE T helper epitope and carbohydrate B cell epitope conjugates induce specific high titer IgG antibody responses.

Alexander J, del Guercio MF, Maewal A, Qiao L, Fikes J, Chesnut RW, Paulson J, Bundle DR, DeFrees S, Sette A.

J Immunol. 2000 Feb 1;164(3):1625-33.

10.

Conserved MHC class I peptide binding motif between humans and rhesus macaques.

Dzuris JL, Sidney J, Appella E, Chesnut RW, Watkins DI, Sette A.

J Immunol. 2000 Jan 1;164(1):283-91.

11.

Immunization with the HBV core 18-27 epitope elicits CTL responses in humans expressing different HLA-A2 supertype molecules.

Livingston BD, Crimi C, Fikes J, Chesnut RW, Sidney J, Sette A.

Hum Immunol. 1999 Nov;60(11):1013-7.

PMID:
10599997
12.

Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes.

Ishioka GY, Fikes J, Hermanson G, Livingston B, Crimi C, Qin M, del Guercio MF, Oseroff C, Dahlberg C, Alexander J, Chesnut RW, Sette A.

J Immunol. 1999 Apr 1;162(7):3915-25.

13.

Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans.

Livingston BD, Alexander J, Crimi C, Oseroff C, Celis E, Daly K, Guidotti LG, Chisari FV, Fikes J, Chesnut RW, Sette A.

J Immunol. 1999 Mar 1;162(5):3088-95.

14.

Lipopeptide particles as the immunologically active component of CTL inducing vaccines.

Tsunoda I, Sette A, Fujinami RS, Oseroff C, Ruppert J, Dahlberg C, Southwood S, Arrhenius T, Kuang LQ, Kubo RT, Chesnut RW, Ishioka GY.

Vaccine. 1999 Feb 26;17(7-8):675-85.

PMID:
10067673
15.

The optimization of helper T lymphocyte (HTL) function in vaccine development.

Alexander J, Fikes J, Hoffman S, Franke E, Sacci J, Appella E, Chisari FV, Guidotti LG, Chesnut RW, Livingston B, Sette A.

Immunol Res. 1998;18(2):79-92. Review.

PMID:
9844827
16.

Recognition of a novel naturally processed, A2 restricted, HCV-NS4 epitope triggers IFN-gamma release in absence of detectable cytopathicity.

Alexander J, Del Guercio MF, Fikes JD, Chesnut RW, Chisari FV, Chang KM, Appella E, Sette A.

Hum Immunol. 1998 Dec;59(12):776-82.

PMID:
9831133
17.

Pools of lipidated HTL-CTL constructs prime for multiple HBV and HCV CTL epitope responses.

Oseroff C, Sette A, Wentworth P, Celis E, Maewal A, Dahlberg C, Fikes J, Kubo RT, Chesnut RW, Grey HM, Alexander J.

Vaccine. 1998 May;16(8):823-33.

PMID:
9627940
18.

Several common HLA-DR types share largely overlapping peptide binding repertoires.

Southwood S, Sidney J, Kondo A, del Guercio MF, Appella E, Hoffman S, Kubo RT, Chesnut RW, Grey HM, Sette A.

J Immunol. 1998 Apr 1;160(7):3363-73.

19.

Identification of Db- and Kb-restricted subdominant cytotoxic T-cell responses in lymphocytic choriomeningitis virus-infected mice.

van der Most RG, Murali-Krishna K, Whitton JL, Oseroff C, Alexander J, Southwood S, Sidney J, Chesnut RW, Sette A, Ahmed R.

Virology. 1998 Jan 5;240(1):158-67.

20.
21.

The hepatitis B virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection.

Livingston BD, Crimi C, Grey H, Ishioka G, Chisari FV, Fikes J, Grey H, Chesnut RW, Sette A.

J Immunol. 1997 Aug 1;159(3):1383-92.

PMID:
9233635
22.

Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles.

Doolan DL, Hoffman SL, Southwood S, Wentworth PA, Sidney J, Chesnut RW, Keogh E, Appella E, Nutman TB, Lal AA, Gordon DM, Oloo A, Sette A.

Immunity. 1997 Jul;7(1):97-112.

23.

Uncovering subdominant cytotoxic T-lymphocyte responses in lymphocytic choriomeningitis virus-infected BALB/c mice.

van der Most RG, Concepcion RJ, Oseroff C, Alexander J, Southwood S, Sidney J, Chesnut RW, Ahmed R, Sette A.

J Virol. 1997 Jul;71(7):5110-4.

24.

Comparison of cytotoxic T lymphocyte responses induced by peptide or DNA immunization: implications on immunogenicity and immunodominance.

Vitiello A, Sette A, Yuan L, Farness P, Southwood S, Sidney J, Chesnut RW, Grey HM, Livingston B.

Eur J Immunol. 1997 Mar;27(3):671-8.

PMID:
9079808
25.

Two distinct HLA-A*0101-specific submotifs illustrate alternative peptide binding modes.

Kondo A, Sidney J, Southwood S, del Guercio MF, Appella E, Sakamoto H, Grey HM, Celis E, Chesnut RW, Kubo RT, Sette A.

Immunogenetics. 1997;45(4):249-58.

PMID:
9002445
26.

Immunodominance analysis of CTL responses to influenza PR8 virus reveals two new dominant and subdominant Kb-restricted epitopes.

Vitiello A, Yuan L, Chesnut RW, Sidney J, Southwood S, Farness P, Jackson MR, Peterson PA, Sette A.

J Immunol. 1996 Dec 15;157(12):5555-62.

PMID:
8955206
27.

Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection.

van der Most RG, Sette A, Oseroff C, Alexander J, Murali-Krishna K, Lau LL, Southwood S, Sidney J, Chesnut RW, Matloubian M, Ahmed R.

J Immunol. 1996 Dec 15;157(12):5543-54.

PMID:
8955205
28.

Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules.

Sidney J, Southwood S, del Guercio MF, Grey HM, Chesnut RW, Kubo RT, Sette A.

J Immunol. 1996 Oct 15;157(8):3480-90.

PMID:
8871647
29.

Identification of A2-restricted hepatitis C virus-specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genome.

Wentworth PA, Sette A, Celis E, Sidney J, Southwood S, Crimi C, Stitely S, Keogh E, Wong NC, Livingston B, Alazard D, Vitiello A, Grey HM, Chisari FV, Chesnut RW, Fikes J.

Int Immunol. 1996 May;8(5):651-9.

PMID:
8671652
30.

Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules.

Sidney J, Grey HM, Southwood S, Celis E, Wentworth PA, del Guercio MF, Kubo RT, Chesnut RW, Sette A.

Hum Immunol. 1996 Feb;45(2):79-93.

PMID:
8882405
31.

Differences and similarities in the A2.1-restricted cytotoxic T cell repertoire in humans and human leukocyte antigen-transgenic mice.

Wentworth PA, Vitiello A, Sidney J, Keogh E, Chesnut RW, Grey H, Sette A.

Eur J Immunol. 1996 Jan;26(1):97-101.

PMID:
8566090
32.

Prominent roles of secondary anchor residues in peptide binding to HLA-A24 human class I molecules.

Kondo A, Sidney J, Southwood S, del Guercio MF, Appella E, Sakamoto H, Celis E, Grey HM, Chesnut RW, Kubo RT, Sette A.

J Immunol. 1995 Nov 1;155(9):4307-12.

PMID:
7594589
33.

In vitro induction of primary, antigen-specific CTL from human peripheral blood mononuclear cells stimulated with synthetic peptides.

Wentworth PA, Celis E, Crimi C, Stitely S, Hale L, Tsai V, Serra HM, Del Guercio MF, Livingston B, Alazard D, Fikes J, Kubo RT, Grey HM, Chesnut RW, Chisari FV, Sette A.

Mol Immunol. 1995 Jun;32(9):603-12.

PMID:
7643853
34.

Design and testing of peptide-based cytotoxic T-cell-mediated immunotherapeutics to treat infectious diseases and cancer.

Chesnut RW, Sette A, Celis E, Wentworth P, Kubo RT, Alexander J, Ishioka G, Vitiello A, Grey HM.

Pharm Biotechnol. 1995;6:847-74. Review. No abstract available.

PMID:
7551252
35.

The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.

Sette A, Vitiello A, Reherman B, Fowler P, Nayersina R, Kast WM, Melief CJ, Oseroff C, Yuan L, Ruppert J, Sidney J, del Guercio MF, Southwood S, Kubo RT, Chesnut RW, Grey HM, Chisari FV.

J Immunol. 1994 Dec 15;153(12):5586-92.

PMID:
7527444
36.

Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes.

Celis E, Tsai V, Crimi C, DeMars R, Wentworth PA, Chesnut RW, Grey HM, Sette A, Serra HM.

Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2105-9.

38.

cDNA cloning and immunological characterization of the rye grass allergen Lol p I.

Perez M, Ishioka GY, Walker LE, Chesnut RW.

J Biol Chem. 1990 Sep 25;265(27):16210-5.

39.

Characterization of the specificity of peptide binding to four DR haplotypes.

O'Sullivan D, Sidney J, Appella E, Walker L, Phillips L, Colón SM, Miles C, Chesnut RW, Sette A.

J Immunol. 1990 Sep 15;145(6):1799-808.

PMID:
2167910
40.

Induction of class I MHC-restricted, peptide-specific cytolytic T lymphocytes by peptide priming in vivo.

Ishioka GY, Colon S, Miles C, Grey HM, Chesnut RW.

J Immunol. 1989 Aug 15;143(4):1094-100.

PMID:
2787356
43.
44.

Capacity of B cells to function as stimulators of a primary mixed leukocyte reaction.

Krieger JI, Chesnut RW, Grey HM.

J Immunol. 1986 Nov 15;137(10):3117-23.

PMID:
2945857
45.

Ia-specific mixed leukocyte reactive T cell hybridomas: analysis of their specificity by using purified class II MHC molecules in synthetic membrane system.

Coeshott CM, Chesnut RW, Kubo RT, Grammer SF, Jenis DM, Grey HM.

J Immunol. 1986 Apr 15;136(8):2832-8.

PMID:
2420871
46.

Antigen presentation by B cells and its significance in T-B interactions.

Chesnut RW, Grey HM.

Adv Immunol. 1986;39:51-94. Review. No abstract available.

PMID:
3538822
47.
48.

Antigen presenting cells and mechanisms of antigen presentation.

Chesnut RW, Grey HM.

Crit Rev Immunol. 1985;5(3):263-316. Review.

PMID:
3884274
49.

Mechanisms of antigen processing and presentation.

Grey HM, Chesnut RW, Shimonkevitz R, Marrack P, Kappler J.

Immunobiology. 1984 Dec;168(3-5):202-12. No abstract available.

PMID:
6335703
50.

Macrophage-dependent activation of antigen-specific T cells requires antigen and a soluble monokine.

DeFreitas EC, Chesnut RW, Grey HM, Chiller JM.

J Immunol. 1983 Jul;131(1):23-9.

PMID:
6190909

Supplemental Content

Loading ...
Support Center